vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $34.3M, roughly 1.5× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -71.6%, a 69.8% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -11.8%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-24.9M). Over the past eight quarters, Clearfield, Inc.'s revenue compounded faster (-3.5% CAGR vs -11.9%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

CLFD vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.5× larger
MRVI
$49.9M
$34.3M
CLFD
Growing faster (revenue YoY)
CLFD
CLFD
+8.6% gap
CLFD
-3.2%
-11.8%
MRVI
Higher net margin
CLFD
CLFD
69.8% more per $
CLFD
-1.8%
-71.6%
MRVI
More free cash flow
CLFD
CLFD
$22.5M more FCF
CLFD
$-2.4M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
CLFD
CLFD
Annualised
CLFD
-3.5%
-11.9%
MRVI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
MRVI
MRVI
Revenue
$34.3M
$49.9M
Net Profit
$-614.0K
$-35.7M
Gross Margin
33.2%
25.8%
Operating Margin
-5.3%
-117.9%
Net Margin
-1.8%
-71.6%
Revenue YoY
-3.2%
-11.8%
Net Profit YoY
67.8%
-37.7%
EPS (diluted)
$-0.04
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
MRVI
MRVI
Q4 25
$34.3M
$49.9M
Q3 25
$23.4M
$41.6M
Q2 25
$49.9M
$47.4M
Q1 25
$47.2M
$46.9M
Q4 24
$29.7M
$56.6M
Q3 24
$5.6M
$69.0M
Q2 24
$48.8M
$69.4M
Q1 24
$36.9M
$64.2M
Net Profit
CLFD
CLFD
MRVI
MRVI
Q4 25
$-614.0K
$-35.7M
Q3 25
$-9.1M
$-25.6M
Q2 25
$1.6M
$-39.6M
Q1 25
$1.3M
$-29.9M
Q4 24
$-1.9M
$-25.9M
Q3 24
$-97.1M
Q2 24
$-447.0K
$-9.8M
Q1 24
$-5.9M
$-12.1M
Gross Margin
CLFD
CLFD
MRVI
MRVI
Q4 25
33.2%
25.8%
Q3 25
53.2%
13.6%
Q2 25
30.5%
16.4%
Q1 25
30.1%
16.5%
Q4 24
29.2%
34.3%
Q3 24
46.7%
Q2 24
21.9%
44.4%
Q1 24
7.7%
40.3%
Operating Margin
CLFD
CLFD
MRVI
MRVI
Q4 25
-5.3%
-117.9%
Q3 25
10.3%
-98.6%
Q2 25
3.0%
-139.8%
Q1 25
0.6%
-104.9%
Q4 24
-6.9%
-66.7%
Q3 24
-239.9%
Q2 24
-4.7%
-19.4%
Q1 24
-26.4%
-29.4%
Net Margin
CLFD
CLFD
MRVI
MRVI
Q4 25
-1.8%
-71.6%
Q3 25
-38.8%
-61.4%
Q2 25
3.2%
-83.5%
Q1 25
2.8%
-63.9%
Q4 24
-6.4%
-45.8%
Q3 24
-140.6%
Q2 24
-0.9%
-14.1%
Q1 24
-16.0%
-18.8%
EPS (diluted)
CLFD
CLFD
MRVI
MRVI
Q4 25
$-0.04
$-0.24
Q3 25
$-0.65
$-0.18
Q2 25
$0.11
$-0.27
Q1 25
$0.09
$-0.21
Q4 24
$-0.13
$-0.21
Q3 24
$-0.68
Q2 24
$-0.04
$-0.07
Q1 24
$-0.40
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$96.4M
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$249.7M
$212.4M
Total Assets
$268.1M
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
MRVI
MRVI
Q4 25
$96.4M
$216.9M
Q3 25
$106.0M
$243.6M
Q2 25
$117.2M
$269.9M
Q1 25
$112.0M
$285.1M
Q4 24
$113.0M
$322.4M
Q3 24
$129.0M
$578.2M
Q2 24
$123.8M
$573.2M
Q1 24
$142.9M
$561.7M
Total Debt
CLFD
CLFD
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$2.2M
$521.7M
Q2 24
$2.1M
$522.5M
Q1 24
$523.3M
Stockholders' Equity
CLFD
CLFD
MRVI
MRVI
Q4 25
$249.7M
$212.4M
Q3 25
$256.2M
$245.4M
Q2 25
$264.5M
$265.9M
Q1 25
$265.9M
$300.6M
Q4 24
$267.4M
$325.3M
Q3 24
$275.8M
$344.9M
Q2 24
$274.6M
$434.7M
Q1 24
$279.2M
$410.7M
Total Assets
CLFD
CLFD
MRVI
MRVI
Q4 25
$268.1M
$770.6M
Q3 25
$306.2M
$849.2M
Q2 25
$314.7M
$897.0M
Q1 25
$310.9M
$959.8M
Q4 24
$303.2M
$1.0B
Q3 24
$315.3M
$1.3B
Q2 24
$318.1M
$1.4B
Q1 24
$315.4M
$1.4B
Debt / Equity
CLFD
CLFD
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
0.01×
1.51×
Q2 24
0.01×
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
MRVI
MRVI
Operating Cash FlowLast quarter
$-1.4M
$-22.8M
Free Cash FlowOCF − Capex
$-2.4M
$-24.9M
FCF MarginFCF / Revenue
-7.1%
-49.9%
Capex IntensityCapex / Revenue
2.9%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
MRVI
MRVI
Q4 25
$-1.4M
$-22.8M
Q3 25
$-15.2M
Q2 25
$7.9M
$-10.3M
Q1 25
$3.0M
$-9.4M
Q4 24
$7.2M
$-14.6M
Q3 24
$22.2M
$13.1M
Q2 24
$4.0M
$17.4M
Q1 24
$-5.7M
$-8.5M
Free Cash Flow
CLFD
CLFD
MRVI
MRVI
Q4 25
$-2.4M
$-24.9M
Q3 25
$-18.1M
Q2 25
$7.5M
$-13.1M
Q1 25
$654.0K
$-14.6M
Q4 24
$5.1M
$-20.5M
Q3 24
$18.2M
$4.5M
Q2 24
$2.8M
$7.9M
Q1 24
$-7.7M
$-14.1M
FCF Margin
CLFD
CLFD
MRVI
MRVI
Q4 25
-7.1%
-49.9%
Q3 25
-43.4%
Q2 25
15.1%
-27.7%
Q1 25
1.4%
-31.2%
Q4 24
17.1%
-36.2%
Q3 24
323.0%
6.6%
Q2 24
5.8%
11.4%
Q1 24
-20.8%
-22.0%
Capex Intensity
CLFD
CLFD
MRVI
MRVI
Q4 25
2.9%
4.2%
Q3 25
2.0%
7.0%
Q2 25
0.8%
6.1%
Q1 25
5.1%
11.2%
Q4 24
7.0%
10.3%
Q3 24
71.4%
12.4%
Q2 24
2.5%
13.8%
Q1 24
5.3%
8.8%
Cash Conversion
CLFD
CLFD
MRVI
MRVI
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons